Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
Chronic Hepatitis C Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Genotype Medicine & Life Sciences
Interferons Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1999 2020

Research Output 1989 2017

5 Citations

Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: Results of the real-world, clinical practice HCV-TARGET study

Welzel, T. M., Nelson, D. R., Morelli, G., Di Bisceglie, A., Reddy, R. K., Kuo, A., Lim, J. K., Darling, J., Pockros, P., Galati, J. S., Frazier, L. M., Alqahtani, S., Sulkowski, M. S., Vainorius, M., Akushevich, L., Fried, M. W. & Zeuzem, S. Oct 1 2017 In : Gut. 66, 10, p. 1844-1852 9 p.

Research output: Contribution to journalArticle

Ribavirin
Genotype
Safety
Infection
Fibrosis
5 Citations

Ledipasvir–sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders

Walsh, C. E., Workowski, K., Terrault, N. A., Sax, P. E., Cohen, A., Bowlus, C. L., Kim, A. Y., Hyland, R. H., Han, B., Wang, J., Stamm, L. M., Brainard, D. M., McHutchison, J. G., von Drygalski, A., Rhame, F., Fried, M. W., Kouides, P., Balba, G. & Reddy, K. R. Mar 1 2017 In : Haemophilia. 23, 2, p. 198-206 9 p.

Research output: Contribution to journalArticle

Ribavirin
Chronic Hepatitis C
Hemorrhage
Genotype
Infection
3 Citations

HCV Council - critical appraisal of data: Recommendations for clinical practice in a rapidly evolving therapeutic landscape

Reau, N., Fried, M. W., Nelson, D. R., Brown, R. S., Everson, G. T., Gordon, S. C., Jacobson, I. M., Lim, J. K., Pockros, P. J., Reddy, K. R. & Sherman, K. E. Apr 1 2016 In : Liver International. 36, 4, p. 488-502 15 p.

Research output: Contribution to journalArticle

Hepacivirus
Expert Testimony
Chronic Hepatitis C
Therapeutics
Hepatitis C

High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity

Johansson, S., Talloen, W., Tuefferd, M., Darling, J., Fanning, G., Fried, M. W. & Aerssens, J. Mar 1 2016 In : Liver International. 36, 3, p. 344-352 9 p.

Research output: Contribution to journalArticle

Ribavirin
Hepacivirus
Genotype
Chemokines
Dipeptidyl Peptidase 4
53 Citations

Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network

Brown, R. S., O'Leary, J. G., Reddy, K. R., Kuo, A., Morelli, G. J., Burton, J. R., Stravitz, R. T., Durand, C., Di Bisceglie, A. M., Kwo, P., Frenette, C. T., Stewart, T. G., Nelson, D. R., Fried, M. W. & Terrault, N. A. Jan 1 2016 In : Liver Transplantation. 22, 1, p. 24-33 10 p.

Research output: Contribution to journalArticle

Therapeutic Human Experimentation
Hepatitis C
Interferons
Registries
Genotype